FergusonCM, SwaroopMN, HorickN, SkolnyMN, MillerCL, JammalloLS, BrunelleC, O'TooleJA, SalamaL, SpechtMC, TaghianAG. Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer. J Clin Oncol, 2016; 34:691–698.
3.
AhnS, PortER. Lymphedema precautions: Time to abandon old practices?. J Clin Oncol., 2016; 34:655–658.
4.
Reply to J. Nudelman. Asdourian, MariaS; Skolny, MelissaN; Brunelle, Cheryl; Seward, CaraE; Salama, Laura; Taghian, AlphonseG. Journal of clinical oncology. 2016; 34: 3111–3112
5.
FisherB, AndersonS, BryantJ, MargoleseRG, DeutschM, FisherER, JeongJH, WolmarkN. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med, 2002; 347:1233–1241.
6.
Nattinger, AnnButler, Gottlieb, MarkS, Veum, Judith, Yahnke, David, Goodwin, JamesS. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med, 1992; 326:1102–1107.
7.
JammalloLS, MillerCL, SingerM, et al.Impact of body mass index and weight change on lymphedema risk in patients treated for breast cancer. Breast Cancer Res Treat, 2013; 142:59–67.
8.
WarrenLEG, MillerCL, HorickN, SkolnyMN, JammalloLS, SadekBT, ShenoudaMN, O'TooleJA, MacDonaldSM, SpechtMC, TaghianAG. The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: A prospective cohort study. Int J Radiat Oncol Biol Phys, 2014; 88:565e571.
9.
SpechtMC, MillerCL, RussellTA, et al.Defining a threshold for intervention in breast cancer-related lymphedema: What level of arm volume increase predicts progression?. Breast Cancer Res Treat, 2013; 140:485–494.
10.
Chandra, RaviA, et al.Radiation therapy risk factors for development of lymphedema in patients treated with regional lymph node irradiation for breast cancer. Int J Radiat Oncol Biol Phys, 2015; 91:760–764.
11.
AncukiewiczM, RussellTA, OtooleJ, et al.Standardized method for quantification of developing lymphedema in patients treated for breast cancer. Int J Radiat Oncol Biol Phys, 2011; 79:1436–1443.
12.
MillerCL, SpechtMC, HorickN, SkolnyMN, JammalloLS, O'TooleJ, TaghianAG. A novel, validated method to quantify breast cancer-related lymphedema (BCRL) following bilateral breast surgery. Lymphology, 2013; 46:64–74.
13.
SunF, SkolnyMN, SwaroopMN, RawalB, CatalanoPJ, BrunelleCL, MillerCL, TaghianAG. The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema. Breast Cancer Res Treat, 2016; 157:229–240.
14.
JeffsE, PurushothamA. The prevelance of lymphoedema in women who attended an information and exercise class to reduce the risk of breast cancer-related upper limb lymphoedema. Springerplus, 2016; 5:21.
15.
AsdourianMS, SkolnyMN, BrunelleC, SewardCE, SalamaL, TaghianAG. Precautions for breast cancer-related lymphoedema: Risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis. Lancet Oncol, 2016; 17:e392–e405.
